English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsPanacea biotech

    Panacea Biotech

    Jump to
    • Nalco, Gland Pharma, Panacea Biotech, Ramky Infra in Focus | Stocks On Radar

      Nalco, Gland Pharma, Panacea Biotech, Ramky Infra in Focus | Stocks On Radar

      NALCO signs mining lease deed for Utkal-D & Utkal E-coal block to enhance coal production capacity to 4 MTPA.Gland Pharma says France drug regulator issues 10 observations for Cenexi's Fontenay manufacturing unit. Panacea Biotec receives Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine worth Rs 127 crore in 2025

    • Panacea Biotech slumps 5% after US FDA issues 9 observations on Baddi facility

      Panacea Biotech slumps 5% after US FDA issues 9 observations on Baddi facility

      The USFDA inspected the unit from October 03-12.

    • Vaccine Update | Panacea Biotech share price up 5% after govt pushes for ramp up in production of COVAXIN

      Vaccine Update | Panacea Biotech share price up 5% after govt pushes for ramp up in production of COVAXIN

      BJP National Spokesperson Sambit Patra said Bharat Biotech and Panacea Biotech are equipped with Biosafety level 3, or BSL-3, which is needed to safely handle the deal virus used to produce the vaccine

    • Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

      Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

      DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing.

    • Buy IndusInd Bank, PVR; Trident may test Rs 135: Ashwani Gujral

      Buy IndusInd Bank, PVR; Trident may test Rs 135: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy IndusInd Bank and PVR while he feels that Trident may test Rs 135.

    • Govt nod to 15 FDI plans; CCEA to consider HDFC Bk proposal

      Govt nod to 15 FDI plans; CCEA to consider HDFC Bk proposal

      The proposals were cleared by Foreign Investment Promotion Board (FIPB) headed by the Economic Affairs Secretary in its meeting held earlier this month.

    • Panacea Biotech Q1 net loss at Rs 60.92cr

      Panacea Biotech Q1 net loss at Rs 60.92cr

      Panacea Biotech Ltd today reported net loss of Rs 60.92 crore for the first quarter ended June 30, 2013.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347